TD Securities (USA)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$4K Buy
41
+2
+5% +$193 0.04% 260
2015
Q4
$4K Sell
39
-62
-61% -$6.07K 0.04% 260
2015
Q3
$9K Sell
101
-70,981
-100% -$7.12M 0.08% 264
2015
Q2
$7.54M Buy
71,082
+8,215
+13% +$909K 0.1% 236
2015
Q1
$7.17M Sell
62,867
-3,371
-5% -$385K 0.11% 230
2014
Q4
$7.29M Buy
66,238
+5,380
+9% +$567K 0.1% 237
2014
Q3
$5.94M Buy
60,858
+432
+0.7% +$42.5K 0.1% 245
2014
Q2
$6.09M Buy
60,426
+3,196
+6% +$312K 0.1% 243
2014
Q1
$5.25M Sell
57,230
-4,904
-8% -$452K 0.09% 262
2013
Q4
$5.62M Buy
62,134
+2,341
+4% +$203K 0.09% 259
2013
Q3
$4.77M Buy
59,793
+664
+1% +$52.3K 0.09% 278
2013
Q2
$4.3M Buy
+59,129
New +$4.42M 0.09% 283

Other funds holding ZBH

TD Securities (USA)'s ZBH Position: Q1 2016 in Review

TD Securities (USA) increased its Zimmer Biomet (ZBH) stake by 5.1% in Q1 2016, buying an estimated $193 and bringing the position to 41 shares worth $4K. The position accounts for 0.04% of the portfolio, ranked #260.

TD Securities (USA) first reported a position in ZBH in Q2 2013 and has held it in 12 quarters since. The position peaked at $7.54M in Q2 2015. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

  • TD Securities (USA) held 41 shares of Zimmer Biomet worth $4K as of Q1 2016.
  • TD Securities (USA) bought 2 Zimmer Biomet shares in Q1 2016, an estimated $193.
  • Zimmer Biomet made up 0.04% of TD Securities (USA)'s portfolio in Q1 2016, its #260 holding.
  • TD Securities (USA) first reported a position in Zimmer Biomet in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Zimmer Biomet position peaked at $7.54M in Q2 2015.
  • 746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.